Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$280.61 - $420.45 $11.6 Million - $17.3 Million
-41,237 Closed
0 $0
Q1 2022

Apr 29, 2022

SELL
$357.49 - $445.92 $585,926 - $730,862
-1,639 Reduced 3.82%
41,237 $16.9 Million
Q4 2021

Feb 14, 2022

BUY
$402.25 - $471.34 $84,070 - $98,510
209 Added 0.49%
42,876 $20.1 Million
Q3 2021

Oct 28, 2021

BUY
$363.01 - $468.47 $7.25 Million - $9.36 Million
19,972 Added 88.0%
42,667 $18.1 Million
Q2 2021

Aug 09, 2021

BUY
$284.77 - $363.2 $501,479 - $639,595
1,761 Added 8.41%
22,695 $8.15 Million
Q1 2021

May 12, 2021

BUY
$257.29 - $307.53 $686,192 - $820,182
2,667 Added 14.6%
20,934 $5.9 Million
Q4 2020

Feb 05, 2021

BUY
$261.16 - $301.66 $533,811 - $616,593
2,044 Added 12.6%
18,267 $5.18 Million
Q3 2020

Nov 09, 2020

BUY
$224.99 - $288.02 $3.65 Million - $4.67 Million
16,223 New
16,223 $4.46 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $23.6B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Navellier & Associates Inc Portfolio

Follow Navellier & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Navellier & Associates Inc with notifications on news.